Question follow-through · 110593
Idiopathic Pulmonary Fibrosis: Drugs
To ask the Secretary of State for Health and Social Care, whether his Department has considered the implications of the UK-US Economic Prosperity Deal for the potential approval of Jascayd (nerandomilast).
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 3 Feb 2026
- Target answer date
- 12 Feb 2026
- Answer
- 12 Feb 2026 · 9 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Economy and business
- NHS: Redundancy Pay · 24 Feb 2026
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Draft Code of Practice on Electronic and Workplace Ballots for Statutory Trade Union Ballots · 15 Jul 2026
- Draft Trade Unions (Permissible Means of Voting) and Employment Rights (Unfair Dismissal) (Amendment) Order 2026 · 15 Jul 2026
- Taxation (Energy and Vehicles) Bill Committee: New Clause 5 · 1 Jul 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
3 Feb 2026
Question tabled
To ask the Secretary of State for Health and Social Care, whether his Department has considered the implications of the UK-US Economic Prosperity Deal for the potential approval of Jascayd (nerandomilast).
12 Feb 2026
Target answer date
Date supplied by the official written-questions record.
12 Feb 2026
Answer published
No specific consideration of the implications of the United Kingdom and United States’ Economic Prosperity Deal for the approval of Jascayd (nernadomilast) has been made. The changes that we are making to the way in which the National Institute for Health...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Idiopathic Pulmonary Fibrosis: Drugs
23 Feb 2026 · To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 12 February 2026 to Question 110592, whether his Department has made an estimate of the earliest date nerandomilist could become available to patients after NICE publishes
NHS: Redundancy Pay
24 Feb 2026 · To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential merits of giving the NHS Staff Council a mandate to negotiate NHS partial retirement and statutory redundancy payments with trade unio
NHS: Redundancy Pay
25 Mar 2026 · To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 18 March 2026 to Question 115765, on NHS: Redundancy Pay, whether he will consider giving the NHS Staff Council a mandate to negotiate NHS partial retirement and statutory
Amyloidosis: Diagnosis
5 Jun 2026 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of access to SAP scanning for amyloidosis diagnosis for NHS patients in England; and what steps he is taking to ensure such diagnostic testin
Amyloidosis: Diagnosis
5 Jun 2026 · To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of trends in the level of provision of SAP scanning for amyloidosis diagnosis for patients; and what assessment he has made of potential challenges to
Medical Treatments: British Nationals Abroad
5 Jun 2026 · To ask the Secretary of State for Health and Social Care, what information his Department holds on the number of people travelling abroad for medical treatment; what estimate he has made of the number of complications caused by overseas treatment requirin
Medical Treatments: British Nationals Abroad
5 Jun 2026 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help improve patient awareness of the potential risks of undergoing medical procedures overseas.